Search results
Results From The WOW.Com Content Network
Blindsight is an experimental medical device developed by Neuralink. [ 1 ] [ 2 ] It has received Breakthrough Device Designation from the US Food and Drugs Administration (FDA) . [ 3 ] [ 4 ]
Nobel Biocare offers dental implants, restorative components, CAD/CAM prosthetics, and biomaterials. Dental implants can replace single or multiple missing teeth. They are placed in a patient's jaw bone to provide a fixation for any prosthetic add-on, such as a crown, similar to the way the root of a tooth provides firm anchoring.
The levonorgestrel implant is a type of long-acting reversible birth control. [5] It primarily works by stopping ovulation and by thickening the mucus around the cervix. [4] A levonorgestrel-releasing implant was approved for medical use in 1983 in Finland and in the United States in 1990. [1]
The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions. It is aimed at speeding up development and review of devices ...
In February 2021, the U.S. Food and Drug Administration (FDA) approved the Patient Specific Talus Spacer 3D-printed talus implant for humanitarian use. [1] The Patient Specific Talus Spacer is the first in the world and first of its kind implant to replace the talus; the bone in the ankle joint that connects the leg and the foot.
The FDA said the recall of the device BioZorb Marker, initiated by Hologic in March, was not a product removal, but a correction. The agency also urged patients to report any side effects they ...
Another way to get a tax break for medical expenses, even if you don’t itemize, is to use tax-free money from a health savings account. But you need to plan in advance.
DBS has been approved by the Food and Drug Administration as a treatment for essential and Parkinsonian tremor and since 1997, [3] and for Parkinson's disease (PD) since 2002. DBS was approved as humanitarian device exemptions for dystonia in 2003, [ 4 ] obsessive–compulsive disorder (OCD) in 2009, and approved for epilepsy in 2018.